Get the Stockscreener App
2.44
0.81%
-0.02
After Hours:
2.45
0.01
+0.41%
Aytu Biopharma Inc stock is traded at $2.44, with a volume of 92,589.
It is down -0.81% in the last 24 hours and up +11.93% over the past month.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
See More
Previous Close:
$2.46
Open:
$2.45
24h Volume:
92,589
Relative Volume:
0.07
Market Cap:
$21.90M
Revenue:
$93.76M
Net Income/Loss:
$-13.68M
P/E Ratio:
-0.9278
EPS:
-2.63
Net Cash Flow:
$8.77M
1W Performance:
-7.92%
1M Performance:
+11.93%
6M Performance:
+46.55%
1Y Performance:
-7.92%
1-Day Range:
$2.36
$2.4599
1-Week Range:
$2.36
$2.70
52-Week Range:
$0.95
$2.85
Aytu Biopharma Inc Stock (AYTU) Company Profile
Name
Aytu Biopharma Inc
Sector
Phone
(720) 437-6580
Address
7900 E. UNION AVENUE, DENVER
Compare AYTU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.44 | 22.08M | 93.76M | -13.68M | 8.77M | -2.63 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Initiated | Lake Street | Buy |
| Jun-30-25 | Initiated | Ascendiant Capital Markets | Buy |
| Mar-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-29-20 | Initiated | H.C. Wainwright | Buy |
Aytu Biopharma Inc Stock (AYTU) Latest News
When is Aytu BioPharma Inc. stock expected to show significant growthAI Powered Review For 2025 - jammulinksnews.com
Multi asset correlation models including Aytu BioPharma Inc.Yield Curve Outlook and Long-Term Implication Summary - Newser
Should I buy Aytu BioPharma Inc. stock before earningsDaily Upside Movement Prediction With Data - Newser
Will Aytu BioPharma Inc. outperform the marketWeekly Portfolio Update with ROI Focus - Newser
How hedge fund analytics apply to Aytu BioPharma Inc. stockScalable Portfolio Growth Suggestions Released - metal.it
Combining price and volume data for Aytu BioPharma Inc.Free Top Gaining Picks With Entry Signals - Newser
Can technical indicators confirm Aytu BioPharma Inc.’s reversalFree Accurate Technical Trend Reversal Picks - Newser
Lake Street Sees Big Upside for Aytu Biosciences (AYTU) After EXXUA Acquisition - MSN
Aytu BioPharma Inc. Stock Performance After Earnings: Historical InsightsReal-Time AI Sentiment and Price Forecast - Newser
Published on: 2025-07-30 02:06:07 - Newser
Why Aytu BioPharma Inc. stock attracts strong analyst attentionFree Reliable Alerts for Daily Stock Movers - Newser
Improved Revenues Required Before Aytu BioPharma, Inc. (NASDAQ:AYTU) Stock's 25% Jump Looks Justified - simplywall.st
What are the latest earnings results for Aytu BioPharma Inc.Free Trading Psychology Coaching - jammulinksnews.com
What is Aytu BioPharma Inc. company’s growth strategyInvest confidently with professional guidance - jammulinksnews.com
What makes Aytu BioPharma Inc. stock price move sharplyUnlock market-leading stock analysis - jammulinksnews.com
Will Aytu BioPharma Inc. outperform the market Free Breakout Entry Signal Confirmation Tool - Newser
Should I hold or sell Aytu BioPharma Inc. stock in 2025Unlock exclusive stock analysis for investors - jammulinksnews.com
How volatile is Aytu BioPharma Inc. stock compared to the marketConsistent high-performance stocks - jammulinksnews.com
Published on: 2025-07-28 02:21:07 - jammulinksnews.com
What are Aytu BioPharma Inc. company’s key revenue driversFree Consultation - jammulinksnews.com
How Aytu BioPharma Inc. stock performs during market volatilityROI Focused Stock Calls - Newser
Sectors Driving Future Growth for Aytu BioPharma Inc. Stock2x Return Forecast - Newser
Does Aytu BioPharma Inc. stock perform well during market downturnsCapitalize on emerging trends for profits - jammulinksnews.com
Aytu BioPharma Inc. Stock Analysis and ForecastUnprecedented growth rates - PrintWeekIndia
What analysts say about Aytu BioPharma Inc. stockDynamic profit opportunities - PrintWeekIndia
What risks could impact Aytu BioPharma Inc. stock performanceHigh-velocity capital appreciation - jammulinksnews.com
What drives Aytu BioPharma Inc. stock priceExplosive trading growth - Autocar Professional
What analysts say about Aytu BioPharma Inc. stock outlookJaw-dropping returns - jammulinksnews.com
Is Aytu BioPharma Inc. a good long term investmentConsistent high-performance stocks - jammulinksnews.com
Aytu Biopharma Inc Stock (AYTU) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):